Annual ROE
-69.00%
-28.36%-69.78%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual return on equity is -69.00%, with the most recent change of -28.36% (-69.78%) on December 31, 2023.
- During the last 3 years, AVTE annual ROE has fallen by -141.02% (-195.81%).
- AVTE annual ROE is now -175.48% below its all-time high of 91.41%, reached on December 31, 2019.
Performance
AVTE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-90.19%
-6.54%-7.82%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly return on equity is -90.19%, with the most recent change of -6.54% (-7.82%) on September 30, 2024.
- Over the past year, AVTE quarterly ROE has dropped by -28.57% (-46.36%).
- AVTE quarterly ROE is now -205.61% below its all-time high of 85.40%, reached on June 30, 2021.
Performance
AVTE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVTE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.8% | -46.4% |
| 3 y3 years | -195.8% | -46.4% |
| 5 y5 years | -175.5% | -46.4% |
AVTE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -418.0% | at low | -302.1% | at low |
| 5 y | 5-year | -175.5% | at low | -205.6% | at low |
| alltime | all time | -175.5% | at low | -205.6% | at low |
Aerovate Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -90.19%(+7.8%) |
| Jun 2024 | - | -83.65%(+19.1%) |
| Mar 2024 | - | -70.24%(+14.0%) |
| Dec 2023 | -69.00%(+69.8%) | -61.62%(+11.5%) |
| Sep 2023 | - | -55.28%(+12.2%) |
| Jun 2023 | - | -49.26%(+14.3%) |
| Mar 2023 | - | -43.11%(+21.1%) |
| Dec 2022 | -40.64% | -35.59%(+24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -28.64%(+27.7%) |
| Jun 2022 | - | -22.43%(-11.2%) |
| Mar 2022 | - | -25.25%(-13.5%) |
| Dec 2021 | -13.32%(-118.5%) | -29.20%(-48.9%) |
| Sep 2021 | - | -57.16%(-166.9%) |
| Jun 2021 | - | 85.40%(+14.8%) |
| Mar 2021 | - | 74.38%(+3.3%) |
| Dec 2020 | 72.02%(-21.2%) | 72.02% |
| Dec 2019 | 91.41% | - |
FAQ
- What is Aerovate Therapeutics annual return on equity?
- What is the all time high annual ROE for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual ROE year-on-year change?
- What is Aerovate Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly ROE year-on-year change?
What is Aerovate Therapeutics annual return on equity?
The current annual ROE of AVTE is -69.00%
What is the all time high annual ROE for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual return on equity is 91.41%
What is Aerovate Therapeutics annual ROE year-on-year change?
Over the past year, AVTE annual return on equity has changed by -28.36% (-69.78%)
What is Aerovate Therapeutics quarterly return on equity?
The current quarterly ROE of AVTE is -90.19%
What is the all time high quarterly ROE for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly return on equity is 85.40%
What is Aerovate Therapeutics quarterly ROE year-on-year change?
Over the past year, AVTE quarterly return on equity has changed by -28.57% (-46.36%)